Tuesday 4 June 2013

New Muscular Dystrophy Drugs Offer Hope


A drug called ataluren is in phase 3 testing, after showing mixed results in earlier studies. Its maker, PTC Therapeutics Inc., declined to comment because it has filed to go public. Pfizer Inc. says it is in phase 1 testing of an antibody that aims to ...



BY WORLD DRUG TRACKER
DR ANTHONY MELVIN CRASTO

No comments:

Post a Comment